Fractyl Health, Inc.

GUTSNASDAQHealthcareBiotechnology

$0.88- (-)1Y −18.12%

As of Oct 27, 2026 close

Market cap: $139.61M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $0.38$12.24
Volume (live): -
Avg. volume (3M): 812.39K

Fractyl Health, Inc. (GUTS) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Fractyl Health, Inc. stock.

Analyst Consensus Rating

Investment consensus from 5 professional research analysts

Consensus Rating

Buy

Based on 5 unique analysts

(12 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$16.00

+1718.18% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest GUTS Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 22, 2026	Joseph Pantginis	HC Wainwright	Maintains	Buy	$9.00 → $8.00 −1.00 (−11.1%)
Oct 20, 2026	Whitney Ijem	Canaccord Genuity	Reiterates	Buy	$96.00 → $39.00 −57.00 (−59.4%)
Oct 19, 2026	Chase Knickerbocker	Craig-Hallum	Maintains	Buy	$48.00 → $5.00 −43.00 (−89.6%)
Oct 19, 2026	Michael Ulz	Morgan Stanley	Maintains	Hold	$24.00 → $4.00 −20.00 (−83.3%)
Oct 16, 2026	Joseph Pantginis	HC Wainwright	Maintains	Buy	$96.00 → $8.00 −88.00 (−91.7%)
Oct 12, 2026	Jason Gerberry	BofA Securities	Maintains	Buy	$24.00
Oct 5, 2026	Joseph Pantginis	HC Wainwright	Maintains	Buy	$96.00 → $8.00 −88.00 (−91.7%)
Oct 5, 2026	Michael Ulz	Morgan Stanley	Reiterates	Hold	$2.00 → $24.00 +22.00 (+1100.0%)
Sep 2, 2026	Chase Knickerbocker	Craig-Hallum	Maintains	Buy	$4.00
Aug 12, 2026	Whitney Ijem	Canaccord Genuity	Maintains	Buy	$8.00
Aug 11, 2026	Jason Gerberry	BofA Securities	Reiterates	Buy	$2.00
Aug 10, 2026	Jason Gerberry	BofA Securities	Reiterates	Buy	$2.00

Joseph Pantginis

HC Wainwright

BuyMaintains

$9.00 → $8.00

Oct 22

Whitney Ijem

Canaccord Genuity

BuyReiterates

$96.00 → $39.00

Oct 20

Chase Knickerbocker

Craig-Hallum

BuyMaintains

$48.00 → $5.00

Oct 19

Michael Ulz

Morgan Stanley

HoldMaintains

$24.00 → $4.00

Oct 19

Joseph Pantginis

HC Wainwright

BuyMaintains

$96.00 → $8.00

Oct 16

Jason Gerberry

BofA Securities

BuyMaintains

$24.00

Oct 12

Joseph Pantginis

HC Wainwright

BuyMaintains

$96.00 → $8.00

Oct 5

Michael Ulz

Morgan Stanley

HoldReiterates

$2.00 → $24.00

Oct 5

Chase Knickerbocker

Craig-Hallum

BuyMaintains

$4.00

Sep 2

Whitney Ijem

Canaccord Genuity

BuyMaintains

$8.00

Aug 12

Jason Gerberry

BofA Securities

BuyReiterates

$2.00

Aug 11

Jason Gerberry

BofA Securities

BuyReiterates

$2.00

Aug 10

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 22, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for GUTS?

The analyst consensus rating for GUTS is Buy, based on the latest ratings from 5 analysts over the last 90 days.

What is the average price target for GUTS?

The average 12-month price target for GUTS is $16.00, representing an upside of 1718.2% from the Oct 27, 2026 close of $0.88.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.